抗体
试剂盒
多肽
蛋白
组织芯片
产品中心
Product Center
Research Grade Plamotamab
All
TD-HY257176_1.jpg
- Catalog： TD-HY257176
- Clonality： mAb
- Application： Research Grade Biosimilar
- Synonyms： Bispecific, XmAb-13676, CAS: 2138442-31-4
-
规格：
1mg
-
价格：
¥询价
定制服务咨询
Research Grade Plamotamab
| Catalog No. | TD-HY257176 |
|---|---|
| Species reactivity | Human |
| Applications | Research Grade Biosimilar |
| Host species | Humanized |
| Isotype | IgG1-kappa/scFv-h-CH2-CH3 |
| Expression system | Mammalian Cells |
| Species | Human |
| Clonality | Monoclonal |
| Target | B-lymphocyte surface antigen B1, Membrane-spanning 4-domains subfamily A member 1, MS4A1, Leukocyte surface antigen Leu-16, B-lymphocyte antigen CD20, Bp35, CD20, T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain |
| Endotoxin level | Please contact with the lab for this information. |
| Purity | >95% as determined by SDS-PAGE. |
| Purification | Protein A/G purified from cell culture supernatant. |
| Accession | P11836 & P07766 |
| Form | Liquid |
| Storage buffer | 0.01M PBS, pH 7.4. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
| Alternate Names | Bispecific, XmAb-13676, CAS: 2138442-31-4 |
| Background | Plamotamab (XmAb-13676) is a human bispecific antibody (bsAb) that binds CD3 and CD20. Plamotamab recruits cytotoxic T cells to kill CD20+ expressing tumor cells. Plamotamab induces a mild hematologic reaction (MR), and results in tumor regression in vivo. |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
|
|
Detects Recombinant Human CD20/MS4A1 Protein, N-His (Cat No.:TD-HY257011) in indirect ELISA. |